Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

October 31, 2000

Conditions
Bullous Pemphigoid
Interventions
DRUG

Azathioprine or Mycophenolate mofetil

Trial Locations (11)

24105

Dermatology, Univ. of Kiel, Kiel

30449

Dermatology, Univ. Hospital Hannover, Hanover

32423

Dermatology, Municipal Hospital Minden, Minden

37075

Dermatology, Univ. of Goettingen, Göttingen

39120

Dermatology, Univ. of Magdeburg, Magdeburg

40225

Dermatology, Univ. of Duesseldorf, Düsseldorf

50931

Dermatology, Univ. of Cologne, Cologne

68167

Dermatology, Medical Faculty Mannheim, Univ. of Heidelberg, Mannheim

89081

Dermatology, Univ. of Ulm, Ulm

97080

Dermatology, Univ. of Wuerzburg, Würzburg

01307

Dermatology, Univ. of Dresden, Dresden

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University Hospital Muenster

OTHER

NCT00431119 - Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid | Biotech Hunter | Biotech Hunter